HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of anakinra, an IL1 receptor antagonist, in refractory Sweet syndrome.

AuthorsA Delluc, N Limal, X Puéchal, C Francès, J C Piette, P Cacoub
JournalAnnals of the rheumatic diseases (Ann Rheum Dis) Vol. 67 Issue 2 Pg. 278-9 (Feb 2008) ISSN: 1468-2060 [Electronic] England
PMID18192308 (Publication Type: Case Reports, Letter)
Chemical References
  • Dermatologic Agents
  • Interleukin 1 Receptor Antagonist Protein
  • Receptors, Interleukin-1
Topics
  • Dermatologic Agents (therapeutic use)
  • Female
  • Humans
  • Interleukin 1 Receptor Antagonist Protein (therapeutic use)
  • Middle Aged
  • Receptors, Interleukin-1 (therapeutic use)
  • Sweet Syndrome (drug therapy)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: